Finerenone for Prevention of First-Detected AF Across the Cardio-Kidney-Metabolic Spectrum: Insights From the FINE-HEART Pooled Analysis

Jonathan P Piccini; Adam D DeVore; Marat Fudim

doi:10.1016/j.jacc.2025.03.513

Finerenone for Prevention of First-Detected AF Across the Cardio-Kidney-Metabolic Spectrum: Insights From the FINE-HEART Pooled Analysis

J Am Coll Cardiol. 2025 May 6;85(17):1661-1663. doi: 10.1016/j.jacc.2025.03.513. Epub 2025 Mar 24.

Authors

Jonathan P Piccini¹, Adam D DeVore², Marat Fudim²

Affiliations

¹ Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA. Electronic address: jonathan.piccini@duke.edu.
² Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.

PMID: 40306838
DOI: 10.1016/j.jacc.2025.03.513

No abstract available

Keywords: atrial fibrillation; chronic kidney disease; heart failure with preserved ejection fraction; mineralocorticoid receptor antagonists; prevention.

Publication types

Editorial